🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mateusz Opyrchal

Indiana University Health

ORCID: 0000-0003-2454-7441

Also affiliated with Roswell Park Comprehensive Cancer Center, Washington University in St. Louis, Indiana Cancer Consortium, Indiana University Bloomington, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

EBioMedicine(2022)10.1016/j.ebiom.2022.104316

Top 20%

1.0DataRank

Top 20%17 citations

Lorenzo Gerratana, Katherine Clifton, Arielle J. Medford, Marko Velimirovic, Whitney L. Hensing +17 more

Papers

Driven by 16 papers — median percentile 80. Top paper: “Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer”.

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06307-3

N/A

1.1DataRank · unranked

35 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

EBioMedicine(2022)10.1016/j.ebiom.2022.104316

Top 20%

1.0DataRank

Top 20%17 citations

Lorenzo Gerratana, Katherine Clifton, Arielle J. Medford, Marko Velimirovic, Whitney L. Hensing +17 more

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3305

N/A

0.725DataRank · unranked

125 citations

Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich +15 more

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

npj Breast Cancer(2023)10.1038/s41523-022-00504-z

N/A

0.705DataRank · unranked

23 citations

Donald W. Northfelt, Tracey L. O’Connor, Ellis Levine, Jingqin Luo, Yu Tao +16 more

Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression

Journal of Clinical Investigation(2022)10.1172/jci158661

N/A

0.584DataRank · unranked

48 citations

Andrea M. Amitrano, Robert Zollo, Jennifer Peresie, Elliot D. Kramer, Brian Morreale +9 more

Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007381

N/A

0.442DataRank · unranked

18 citations

Mateusz Opyrchal, Melissa Grimm, Ronald Slomba, Kathleen M. Kokolus, Agnieszka K. Witkiewicz +13 more

Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression

iScience(2024)10.1016/j.isci.2024.109187

N/A

0.241DataRank · unranked

4 citations

Elliot D. Kramer, Hemn Mohammadpour, Minhyung Kim, Spencer R. Rosario, Han Yu +14 more

Immunogenomic Profiling and Pathological Response Results From a Clinical Trial of Docetaxel and Carboplatin in Triple Negative Breast Cancer

Research Square(2021)10.21203/rs.3.rs-420931/v1

N/A

0.104DataRank · unranked

1 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Forward genetics identifies HN1L/JPT2 as a novel carboplatin resistance gene in ovarian cancer

Genes & Diseases(2025)10.1016/j.gendis.2025.101720

N/A

0DataRank · unranked

0 citations

Aishat Motolani, Kenneth P. Nephew, Guanglong Jiang, Faranak Alipourgivi, Steven Sun +6 more

Functional hotness score based on three genes predicts long-term survival of triple-negative breast cancer independent from tumor mutational burden.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e12583

N/A

0DataRank · unranked

0 citations

Li Yan, Mateusz Opyrchal, Paweł Kaliński, Kazuaki Takabe, Eriko Katsuta

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer

Therapeutic Advances in Medical Oncology(2021)10.1177/17588359211006680

N/A

0DataRank · unranked

17 citations

Li Yan, Mateusz Opyrchal, Paweł Kaliński, Kazuaki Takabe, Eriko Katsuta

Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?

Cancers(2022)10.3390/cancers14081856

N/A

0DataRank · unranked

29 citations

Arya Mariam Roy, Ashish Gupta, Kazuaki Takabe, Ajay Dhakal, Mateusz Opyrchal +3 more

Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression?

Journal of Clinical Investigation(2022)10.1172/jci163010

N/A

0DataRank · unranked

15 citations

Mateusz Opyrchal, Xiongbin Lu, Samantha Sharma

Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies

Clinical Trials(2024)10.1177/17407745231220661

N/A

0DataRank · unranked

16 citations

Beibei Guo, Yingjie Qiu, Hao Liu, Mateusz Opyrchal, Xiongbin Lu +1 more

Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-010058

N/A

0DataRank · unranked

8 citations

Ronald Slomba, Cayla Janes, Victoria Fitzpatrick, Janine Miller, Kristopher Attwood +19 more

Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors

Current Breast Cancer Reports(2025)10.1007/s12609-025-00582-5

N/A

0DataRank · unranked

11 citations

Mateusz Opyrchal, Alo Ray